China Science Daily: Phil Rivers has developed a new scoring system for breast cancer typing based on embryonic genes
 
2022-01-01 17:45:31 文章來(lái)源:China Science Daily
 

Recently, EBioMedicine, a comprehensive sub journal of The Lancet, published a research result on the   exploration of the etiology and scoring system of breast cancer. The research   was jointly completed by the computational medicine team of Phil Rivers, Guangdong Provincial People's Hospital, Turing Darwin Laboratory,   and other research institutions.

Based on the new technology   system of computational medicine, the research team took female breast cancer   as the specific research object and carried out the world's first clinical   trial of embryoline genome etiology. The project team has developed a system   called " Damage Assessment of Genomic Mutations" (DAGM), which has   greatly improved the research level of breast cancer etiology in China. In   the future, APSPs (Activity Profiles of Signalling Pathways) scoring method   will be used to guide the early prevention and early diagnosis of breast cancer.


1657155469121087.png


   

Publication: DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations


Source: China Science Daily



版權聲明(míng):凡本站(zhàn)注明(míng)來(lái)源非哲源科技(jì)的文章,目的在于傳播,如需轉載,請(qǐng)與稿件來(lái)源方聯系,如産生(shēng)任何問題與本站(zhàn)無關:凡本站(zhàn)所發布的圖片、視(shì)頻等素材,版權歸原作(zuò)者 所有(yǒu),僅供學習與研究,如有(yǒu)侵權,請(qǐng)提供版權證明(míng),以便盡快删除。

掃一掃關注公衆号